SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression

Junji Otani1,2, Miki Nishio1, Riko Tokita1

  • 1Division of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe, Japan.

Oncogene
|April 21, 2026
PubMed

Insights

SAMD4A/B proteins promote cancer by destabilizing VGLL4 mRNA, which activates YAP1/TAZ-TEAD transcription. Inhibiting SAMD4A/B boosts VGLL4, suppressing cancer progression and TEAD activity.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • YAP1 and TAZ are transcriptional cofactors that bind TEAD, driving cancer initiation, progression, and drug resistance.
  • SAMD4A/B are RNA-binding proteins with largely unknown functions; their Drosophila homolog Smaug affects mRNA stability and translation.
  • The YAP1/TAZ-TEAD pathway is a critical therapeutic target in oncology.

Purpose of the Study:

  • To identify novel targets that inhibit the YAP1/TAZ-TEAD oncogenic transcription program.
  • To investigate the role of SAMD4A/B proteins in regulating YAP1/TAZ-TEAD activity and cancer progression.

Main Methods:

  • Whole-genome siRNA library screening to identify suppressors of TEAD activity.
  • Assessing the impact of SAMD4A/B on VGLL4 mRNA stability and translation.
  • In vitro cell-based assays for cancer progression.
  • In vivo studies using transgenic mice with liver-specific SAMD4B expression.

Main Results:

  • siSAMD4B potently suppressed TEAD activity in human cancer cells.
  • SAMD4A/B destabilize and repress VGLL4 mRNA translation, thereby promoting cancer progression.
  • Inhibition of SAMD4A/B increased VGLL4 mRNA, suppressed TEAD activity, and inhibited cancer progression.
  • Liver-specific SAMD4B expression accelerated intrahepatic cholangiocarcinoma development in Nf2-deficient mice.

Conclusions:

  • SAMD4A/B promote cancer progression by negatively regulating VGLL4 mRNA, leading to YAP1/TAZ-TEAD pathway activation.
  • SAMD4A/B represent a promising therapeutic target for developing anticancer drugs that inhibit TEAD activation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

1.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.7K